ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-725-2294, 6505017252294
INFLUENZA VIRUS VACCINE

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 017252294
Codification Country
United States
Item Name Code
INC 22781
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-725-2294
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-725-2294


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-725-2294

National Stock Number (NSN) 6505-01-725-2294, or NIIN 017252294, (influenza virus vaccine) was assigned December 13, 2024 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

This NSN is assigned to Item Name Code (INC) 22781. [A VACCINE INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF INFLUENZA DISEASE CAUSED BY INFLUENZA A SUBTYPE VIRUSES AND TYPE B VIRUSES CONTAINED IN THE VACCINE.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505017252294 does not contain precious metals.

This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.

This information was last updated on .


Technical Characteristics

IMMEDIATE CONTAINER QUANTITY
(ANNX) 1
IMMEDIATE CONTAINER TYPE
(ANNW) VIAL, MULTIPLE DOSE
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) FLUCELVAX MDV TRIVALENT NORTHERN HEMISPHERE MULTI-DOSE VIAL, 5 ML
PROTECTIVE STORAGE FEATURE
(AJCN) REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
SPECIAL FEATURES
(FEAT) FLUCELVAX MDV TRIVALENT NORTHERN HEMISPHERE 2025-2026 FORMULA MULTI-DOSE VIAL, 5 ML. SUPPLIED AS PACKAGE OF ONE. A MAXIMUM OF TEN 0.5 ML DOSES CAN BE WITHDRAWN FROM THE MULTI-DOSE VIAL. FOR IMMUNIZING PERSONS 6 MONTHS AND OLDER; FOR IM ADMINISTRATION; STORE REFRIGERATED AT 2 TO 8 C (35 TO 46 F). DO NOT FREEZE. CONTAINS THIMEROSAL AS A PRESERVATIVE.
VALENCE
(CMDL) TRIVALENT
VIRUS STRAIN
(CMDM) INFLUENZA

Manufacturer Part Numbers


Related Inventory



 
Top